Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
Other companies in Viridian Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Ascentage Pharma Group International (NASDAQ:AAPG), Xenon Pharmaceuticals Inc (NASDAQ:XENE) and Mesoblast Ltd (NASDAQ:MESO).
Viridian Therapeutics has a consensus price target of $39.94.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $33.03 last updated December 15, 2025 at 4:58 PM EST.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.